FAIRMOUNT FUNDS MANAGEMENT LLC sold 75.8% of their position (3.55M shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $300.01M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001104659-26-080009
Director10% Owner
Since Aug 2024
-42.64K
Net shares
Net seller
$300.01M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.55M acquired · 3.60M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+3.55M
Price / share
—
Trade value
—
% of position
313.9%
7/1/2026
1.13M→4.69M
Common Stock
Indirect
Shares
−3.55M
Price / share
$84.43
Trade value
$300.01M
% of position
75.8%
7/1/2026
4.69M→1.13M
Total
Net shares
+0.00
Net value
-$300.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2026 | C · Conversion | +3.55M | — | — | 313.9% | 1.13M | 4.69M |
| Common Stock Indirect | 7/1/2026 | S · Sale | −3.55M | $84.43 | $300.01M | 75.8% | 4.69M | 1.13M |
| Total | +0.00 | -$300.01M | ||||||
Derivative Transactions1
Series B Preferred Stock
Indirect
Converts to
Common Stock
3.55M shares
Shares
−42.64K
Strike price
Held after
94.50K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock3.55M shares | 7/1/2026 | C · Conversion | −42.64K | — | 94.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.57M
Total
2.57M indirect2.57M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.57M | Indirect |
| Total | 2.57M | 2.57M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported